Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Dermatology drugs in the BMS pipeline

April 26, 1996

Hyal-CT1101 effective in phase III trial

April 26, 1996

Iamin gel in phase I in Japan

April 26, 1996

Teva's generic minoxidil approved in U.S.

April 19, 1996

Azelex now available to treat acne

April 12, 1996

ALA-PDT to be studied for hair removal

April 12, 1996

Silkis licensed to Galderma

April 12, 1996

ADCON-L efficacy reported

April 5, 1996

New 5alpha-reductase inhibitor from Merck & Co.

March 26, 1996

Antipsoriatic treatment in development at Immune Response

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...